PyInvesting

Market research

300653.SHE Yantai Zhenghai Biotechnology Co., Ltd

SHE CNY Healthcare

Latest close

13.85 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
35.74
Analyst target
18.935
Dividend yield
1.9%
Beta
0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Yantai Zhenghai Biotechnology Co., Ltd is currently in a long term uptrend where the price is trading 18.0% above its 200 day moving average.

From a valuation standpoint, the stock is 81.7% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 17.5.

Yantai Zhenghai Biotechnology Co., Ltd's total revenue rose by 4.1% to $82M since the same quarter in the previous year.

Its net income has increased by 45.2% to $40M since the same quarter in the previous year.

Finally, its free cash flow grew by 153.6% to $32M since the same quarter in the previous year.

Based on the above factors, Yantai Zhenghai Biotechnology Co., Ltd gets an overall score of 4/5.